Literature DB >> 32959076

Value of serial echocardiography in diagnosing Kawasaki's disease.

Maria Hörl1, Holger Michel1, Stephan Döring1, Markus-Johann Dechant1, Florian Zeman2, Michael Melter1, Stephan Gerling3.   

Abstract

Kawasaki disease (KD) is an acute vasculitis predominantly affecting the small arteries of young children. Up to 25% of untreated patients suffer from coronary artery (CA) complications. Early diagnosis and treatment is mandatory in incomplete KD to reduce the risk of coronary involvement. Between 2002 and 2018, 124 patients have been diagnosed suffering from KD at the University Children's Hospital Regensburg (KUNO). We assessed luminal diameters of both CAs normalized as Z-scores by 2D-echocardiography. A total of 94 patients were analyzed. Of them, 31 (33%) were affected by an incomplete form of KD. In 24 children (26%), serial echocardiography was necessary in order to confirm diagnosis. Mean Z-scores for the left main coronary artery (LMCA), right main coronary artery (RMCA), and left anterior descending artery increased significantly between the initial (LMCA 0.79z, RMCA 0.15z, LAD 0.49z) and second (LMCA 1.69z, RMCA 0.99z, LAD 1.69z) examination (p < 0.05).
Conclusion: To confirm diagnosis of KD, it might not be necessary to detect dilation or aneurysms. Our observation suggests that patients suspected having KD should be monitored with serial echocardiography in order to detect a possible enlargement of the CA diameters, even if Z-scores are within the normal range. What is Known: • Kawasaki disease (KD) is an acute vasculitis predominantly affecting the small arteries of young children. Up to 25% of untreated patients suffer from coronary artery (CA) complications. • Due to less classic clinical criteria in patients with incomplete KD, the risk for CA pathology is even higher. What is New: • A significant progression of patients' CA Z-scores in serial echocardiographic measurements may be helpful to ensure diagnosis of KD early even if Z-scores are within the normal range. • Twenty-seven patients (90%) with incomplete KD could be diagnosed within 10 days of fever, early enough to prevent significantly higher rates of CA aneurysm.

Entities:  

Keywords:  Aneurysm; Coronary arteries; Echocardiography; Immunoglobins intravenous; Kawasaki disease; Vasculitis

Mesh:

Year:  2020        PMID: 32959076      PMCID: PMC7813692          DOI: 10.1007/s00431-020-03752-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  31 in total

1.  Incidence of Kawasaki disease in northern European countries.

Authors:  Eeva Salo; Elizabeth P Griffiths; Teresa Farstad; Bodil Schiller; Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Brookie M Best; Jane C Burns
Journal:  Pediatr Int       Date:  2012-10-08       Impact factor: 1.524

2.  Nationwide survey of Kawasaki disease and acute rheumatic fever.

Authors:  K A Taubert; A H Rowley; S T Shulman
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

3.  Kawasaki disease and giant coronary artery aneurysms: the role of echocardiography from diagnosis through follow-up.

Authors:  Adam C Adler; Ramesh Kodavatiganti
Journal:  Echocardiography       Date:  2016-06-29       Impact factor: 1.724

4.  Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study.

Authors:  Lei Liu; Chunyan Luo; Yimin Hua; Mei Wu; Shuran Shao; Xiaoliang Liu; Kaiyu Zhou; Chuan Wang
Journal:  Eur J Pediatr       Date:  2020-01-24       Impact factor: 3.183

5.  Kawasaki Disease in Germany: A Prospective, Population-based Study Adjusted for Underreporting.

Authors:  André Jakob; Jane Whelan; Matthaeus Kordecki; Reinhard Berner; Brigitte Stiller; Raoul Arnold; Rudiger von Kries; Elena Neumann; Nicholas Roubinis; Mirna Robert; Jochen Grohmann; René Höhn; Markus Hufnagel
Journal:  Pediatr Infect Dis J       Date:  2016-02       Impact factor: 2.129

6.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

7.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

8.  Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with Fever.

Authors:  Andras Bratincsak; Venu D Reddy; Prashant J Purohit; Adriana H Tremoulet; Delaram Pour Molkara; Jeffrey R Frazer; Dan Dyar; Ruth A Bush; James Y Sim; New Sang; Jane C Burns; Marian A Melish
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

9.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease.

Authors:  T E Capannari; S R Daniels; R A Meyer; D C Schwartz; S Kaplan
Journal:  J Am Coll Cardiol       Date:  1986-02       Impact factor: 24.094

View more
  1 in total

1.  Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort.

Authors:  Carlos D Grasa; Elisa Fernández-Cooke; Judith Sánchez-Manubens; Begoña Carazo-Gallego; Javier Aracil-Santos; Jordi Anton; María José Lirola; Beatriz Mercader; Enrique Villalobos; Matilde Bustillo; Gemma Giralt; Beatriz Rocandio; Lucía M Escribano; Sara Domínguez-Rodríguez; Cristina Calvo
Journal:  Eur J Pediatr       Date:  2021-08-30       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.